Improved secretion of neublastin
Details for Australian Patent Application No. 2004245175 (hide)
International Classifications
Event Publications
12 January 2006 PCT application entered the National Phase
PCT publication WO2004/108760 Priority application(s): WO2004/108760
2 March 2006 Amendment Made
The nature of the amendment is: Amend the name of the co-applicant from Biogen Idec MA, Inc. to Biogen Idec MA Inc.
15 October 2009 Application Accepted
Published as AU-B-2004245175
26 November 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 26 Oct 2009. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 26 239 George Street Brisbane QLD 4000
18 March 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 26 Oct 2009
25 March 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser